Co-occurring gene alterations associated with efficacy of osimertinib in EGFR-mutated lung cancer: Based on a large-scale genomic screening project (LC-SCRUM-Asia).
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Yuji Shibata, Shingo Matsumoto, Shunta Mori, Tetsuya Sakai, Hiroki Izumi, Hibiki Udagawa, Kaname Nosaki, Yoshitaka Zenke, Kiyotaka Yoh, Haruko Daga, Atsuhisa Tamura, Jun Sakakibara-Konishi, Shoichi Kuyama, Naoki Furuya, Atsushi Nakamura, Masato Shingyoji, Kazumi Nishino, Terufumi Kato, Susumu Kobayashi, Koichi Goto
Institutions: National Cancer Center Hospital East, Osaka City General Hospital, Tokyo National Hospital, Hokkaido University Hospital, Iwakuni Medical Center, St. Marianna University School of Medicine, Sendai Kousei Hospital, Chiba Cancer Center, Osaka International Cancer Institute, Kanagawa Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4281908453
